Terms: = Lymphoma AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679
528 results:
1. Pre-treatment [
Chen J; Zhao Y
Hematology; 2024 Dec; 29(1):2325317. PubMed ID: 38465661
[TBL] [Abstract] [Full Text] [Related]
2. Childhood-onset systemic lupus erythematosus (cSLE) and malignancy: a nationwide multicentre series review.
Brufatto MZ; Lanças SHS; de Albuquerque Pedrosa Fernandes T; Sallum AME; Campos LMA; Sakamoto AP; Terreri MT; Sztajnbok FR; Bica BERG; Ferriani VPL; de Carvalho LM; Silva CAA; Saad-Magalhaes C
Adv Rheumatol; 2024 Feb; 64(1):13. PubMed ID: 38321580
[TBL] [Abstract] [Full Text] [Related]
3. Pharmacokinetics, metabolism, excretion and safety of iruplinalkib (WX-0593), a novel ALK inhibitor, in healthy subjects: a phase I human radiolabeled mass balance study.
Bian Y; Ma S; Yao Q; Hu T; Ge M; Li H; Zheng S; Gu Z; Feng H; Yu Z; Huang C; Zhang H; Zhao L; Miao L
Expert Opin Investig Drugs; 2024 Jan; 33(1):63-72. PubMed ID: 38224050
[TBL] [Abstract] [Full Text] [Related]
4. Utility of
Chen J; Li XL; Huang M
Clin Radiol; 2024 Mar; 79(3):205-212. PubMed ID: 38218705
[TBL] [Abstract] [Full Text] [Related]
5. MYCT1 inhibits hematopoiesis in diffuse large B-cell lymphoma by suppressing RUNX1 transcription.
Liang Y; Wei X; Yue PJ; Zhang HC; Li ZN; Wang XX; Sun YY; Fu WN
Cell Mol Biol Lett; 2024 Jan; 29(1):5. PubMed ID: 38172714
[TBL] [Abstract] [Full Text] [Related]
6. Deep learning for [
Häggström I; Leithner D; Alvén J; Campanella G; Abusamra M; Zhang H; Chhabra S; Beer L; Haug A; Salles G; Raderer M; Staber PB; Becker A; Hricak H; Fuchs TJ; Schöder H; Mayerhoefer ME
Lancet Digit Health; 2024 Feb; 6(2):e114-e125. PubMed ID: 38135556
[TBL] [Abstract] [Full Text] [Related]
7. Risk of malignancy in incidental oropharyngeal lesions exhibiting fluorodeoxyglucose uptake which proceed to tissue biopsy.
Key S; Chia C; Magarey M; Dixon B
ANZ J Surg; 2024 Feb; 94(1-2):122-127. PubMed ID: 38115646
[TBL] [Abstract] [Full Text] [Related]
8. Evaluation of manual and automated approaches for segmentation and extraction of quantitative indices from [
Krokos G; Kotwal T; Malaih A; Barrington S; Jackson P; Hicks RJ; Marsden PK; Fischer BM
Biomed Phys Eng Express; 2024 Jan; 10(2):. PubMed ID: 38100790
[TBL] [Abstract] [Full Text] [Related]
9. Differentiation of cancer of unknown primary and lymphoma in head and neck metastatic poorly differentiated cancer using 18 F-FDG PET/CT tumor metabolic heterogeneity index.
Xu M; Gu B; Zhang J; Xu X; Qiao Y; Hu S; Song S
Nucl Med Commun; 2024 Feb; 45(2):148-154. PubMed ID: 38095143
[TBL] [Abstract] [Full Text] [Related]
10. CXCR4-directed PET/CT with [
Dreher N; Hahner S; Fuß CT; Schlötelburg W; Hartrampf PE; Serfling SE; Schirbel A; Samnick S; Higuchi T; Weich A; Lapa C; Rosenwald A; Buck AK; Kircher S; Werner RA
Eur J Nucl Med Mol Imaging; 2024 Apr; 51(5):1383-1394. PubMed ID: 38082196
[TBL] [Abstract] [Full Text] [Related]
11. Micafungin twice-a-week for prophylaxis of invasive Aspergillus infections in children with acute lymphoblastic leukaemia: A controlled cohort study.
Bury D; Wolfs TFW; Muilwijk EW; Fiocco M; Pieters R; Brüggemann RJ; Tissing WJE
Int J Antimicrob Agents; 2024 Jan; 63(1):107058. PubMed ID: 38081549
[TBL] [Abstract] [Full Text] [Related]
12. Evaluation of the Effect of Lorlatinib on CYP2B6, CYP2C9, UGT, and P-Glycoprotein Substrates in Patients with Advanced Non-Small Cell Lung Cancer.
Chen J; Bearz A; Kim DW; Mamdani H; Bauman J; Chiari R; Ou SI; Solomon BJ; Soo RA; Felip E; Shaw AT; Thurm H; Clancy JS; Lee K; O'Gorman M; Tanski C; Pithavala YK
Clin Pharmacokinet; 2024 Feb; 63(2):171-182. PubMed ID: 38079095
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic Value of Baseline Tumor Burden and Tumor Dissemination Extracted From 18 F-FDG PET/CT in a Cohort of Adult Patients With Early or Advanced Hodgkin lymphoma.
Mouheb M; Pierre-Jean M; Devillers A; Fermé C; Benchalal M; Manson G; Le Jeune F; Houot R; Palard-Novello X
Clin Nucl Med; 2024 Jan; 49(1):e1-e5. PubMed ID: 38015041
[TBL] [Abstract] [Full Text] [Related]
14. Enterovesical Fistula in a lymphoma Patient Revealed by FDG PET/CT With an Oral Contrast Agents.
Guo L; Shen G
Clin Nucl Med; 2024 Jan; 49(1):e38-e39. PubMed ID: 37976526
[TBL] [Abstract] [Full Text] [Related]
15. Chemokine receptor-targeted PET/CT provides superior diagnostic performance in newly diagnosed marginal zone lymphoma patients: a head-to-head comparison with [
Kosmala A; Duell J; Schneid S; Serfling SE; Higuchi T; Weich A; Lapa C; Hartrampf PE; Raderer M; Einsele H; Buck AK; Topp MS; Schlötelburg W; Werner RA
Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):749-755. PubMed ID: 37943339
[TBL] [Abstract] [Full Text] [Related]
16. Metabolic tumor volume predicts outcome in patients with advanced stage follicular lymphoma from the RELEVANCE trial.
Cottereau AS; Rebaud L; Trotman J; Feugier P; Nastoupil LJ; Bachy E; Flinn IW; Haioun C; Ysebaert L; Bartlett NL; Tilly H; Casasnovas O; Ricci R; Portugues C; Buvat I; Meignan M; Morschhauser F
Ann Oncol; 2024 Jan; 35(1):130-137. PubMed ID: 37898239
[TBL] [Abstract] [Full Text] [Related]
17. Correlation of the apparent diffusion coefficient with the standardized uptake value in meningioma of the skull plane using [68]Ga-DOTATOC PET/MRI.
Milosevic A; Styczen H; Haubold J; Kessler L; Grueneisen J; Li Y; Weber M; Fendler WP; Morawitz J; Damman P; Wrede K; Kebir S; Glas M; Guberina M; Blau T; Schaarschmidt BM; Deuschl C
Nucl Med Commun; 2023 Dec; 44(12):1106-1113. PubMed ID: 37823259
[TBL] [Abstract] [Full Text] [Related]
18. Impact of baseline and interim quantitative PET parameters on outcomes of classical Hodgkin lymphoma.
Santos FM; Marin JFG; Lima MS; Silva-Junior WF; Alves LBO; Moreira FR; Velasques RD; Atanazio MJ; Maia ACA; Buchpiguel CA; Buccheri V; Rocha V
Ann Hematol; 2024 Jan; 103(1):175-183. PubMed ID: 37796339
[TBL] [Abstract] [Full Text] [Related]
19. Can
Monjanel B; Nivaggioni G; Staccini P; Gastaud L; Lassalle S; Baillif S; Tieulie N; Martel A
J Fr Ophtalmol; 2024 Jan; 47(1):103958. PubMed ID: 37758546
[TBL] [Abstract] [Full Text] [Related]
20. Validation of the ΔSUV
Itti E; Blanc-Durand P; Berriolo-Riedinger A; Kanoun S; Kraeber-Bodéré F; Meignan M; Gat E; Gouill SL; Casasnovas RO; Bodet-Milin C
J Nucl Med; 2023 Nov; 64(11):1706-1711. PubMed ID: 37734837
[TBL] [Abstract] [Full Text] [Related]
[Next]
